| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
92050733 |
| 019 ## - |
|---|
| -- |
28692819 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0670841838 : |
| Terms of availability |
$23.00 ($29.99 Can.) |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
AJMA |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC483.5.F55 |
| Item number |
K7 1993 |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 77.5 |
| Item number |
K89L 1993 |
| 069 0# - |
|---|
| -- |
9411232 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.85/27061 |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (OCLC) |
|---|
| -- |
26266 |
| -- |
26266 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
616.8527061 Kra |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Kramer, Peter D. frey50 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Listening to Prozac / |
| Statement of responsibility, etc |
Peter D. Kramer. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York, N.Y., U.S.A. : |
| Name of publisher, distributor, etc |
Viking, |
| Date of publication, distribution, etc |
1993. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xix, 409 p. ; |
| Dimensions |
24 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Makeover -- Compulsion -- Antidepressants -- Sensitivity -- Stress -- Risk -- Formes frustes: low self-esteem -- Formes frustes: inhibition of pleasure, sluggishness of thought -- The message in the capsule. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
69741. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Fluoxetine |
| General subdivision |
Moral and ethical aspects. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Fluoxetine |
| General subdivision |
Social aspects. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Fluoxetine |
| General subdivision |
Psychotropic effects. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Personality change. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Fluoxetine |
| General subdivision |
pharmacology. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Fluoxetine |
| General subdivision |
therapeutic use. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Ethics, Medical. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Personality Development. |
| 961 WL - |
|---|
| -- |
12 |